Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

2 Therapeutics

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
Pepinemab	VX15, VX15/2503	Alzheimer's Disease (Phase 1/2), Huntington's Disease (Phase 2)	Vaccinex, Inc.	Inflammation	Immunotherapy (passive)
Trontinemab	RO7126209, RG6102 , Brain shuttle gantenerumab	Alzheimer's Disease (Phase 1/2)	Hoffmann-La Roche	Amyloid-Related	Immunotherapy (passive)